Impact of the Introduction of a Package of Diagnostic Tools, Diagnostic Algorithm, and Training and Communication on Outpatient Acute Fever Case Management at 3 Diverse Sites in Uganda: Results of a Randomized Controlled Trial.
acute febrile illness
antimicrobial resistance
antimicrobial stewardship
behavior change
point-of-care tests
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213
Informations de publication
Date de publication:
25 07 2023
25 07 2023
Historique:
received:
13
02
2023
medline:
27
7
2023
pubmed:
25
7
2023
entrez:
25
7
2023
Statut:
ppublish
Résumé
Increasing trends of antimicrobial resistance are observed around the world, driven in part by excessive use of antimicrobials. Limited access to diagnostics, particularly in low- and middle-income countries, contributes to diagnostic uncertainty, which may promote unnecessary antibiotic use. We investigated whether introducing a package of diagnostic tools, clinical algorithm, and training-and-communication messages could safely reduce antibiotic prescribing compared with current standard-of-care for febrile patients presenting to outpatient clinics in Uganda. This was an open-label, multicenter, 2-arm randomized controlled trial conducted at 3 public health facilities (Aduku, Nagongera, and Kihihi health center IVs) comparing the proportions of antibiotic prescriptions and clinical outcomes for febrile outpatients aged ≥1 year. The intervention arm included a package of point-of-care tests, a diagnostic and treatment algorithm, and training-and-communication messages. Standard-of-care was provided to patients in the control arm. A total of 2400 patients were enrolled, with 49.5% in the intervention arm. Overall, there was no significant difference in antibiotic prescriptions between the study arms (relative risk [RR]: 1.03; 95% CI: .96-1.11). In the intervention arm, patients with positive malaria test results (313/500 [62.6%] vs 170/473 [35.9%]) had a higher RR of being prescribed antibiotics (1.74; 1.52-2.00), while those with negative malaria results (348/688 [50.6%] vs 376/508 [74.0%]) had a lower RR (.68; .63-.75). There was no significant difference in clinical outcomes. This study found that a diagnostic intervention for management of febrile outpatients did not achieve the desired impact on antibiotic prescribing at 3 diverse and representative health facility sites in Uganda.
Sections du résumé
BACKGROUND
Increasing trends of antimicrobial resistance are observed around the world, driven in part by excessive use of antimicrobials. Limited access to diagnostics, particularly in low- and middle-income countries, contributes to diagnostic uncertainty, which may promote unnecessary antibiotic use. We investigated whether introducing a package of diagnostic tools, clinical algorithm, and training-and-communication messages could safely reduce antibiotic prescribing compared with current standard-of-care for febrile patients presenting to outpatient clinics in Uganda.
METHODS
This was an open-label, multicenter, 2-arm randomized controlled trial conducted at 3 public health facilities (Aduku, Nagongera, and Kihihi health center IVs) comparing the proportions of antibiotic prescriptions and clinical outcomes for febrile outpatients aged ≥1 year. The intervention arm included a package of point-of-care tests, a diagnostic and treatment algorithm, and training-and-communication messages. Standard-of-care was provided to patients in the control arm.
RESULTS
A total of 2400 patients were enrolled, with 49.5% in the intervention arm. Overall, there was no significant difference in antibiotic prescriptions between the study arms (relative risk [RR]: 1.03; 95% CI: .96-1.11). In the intervention arm, patients with positive malaria test results (313/500 [62.6%] vs 170/473 [35.9%]) had a higher RR of being prescribed antibiotics (1.74; 1.52-2.00), while those with negative malaria results (348/688 [50.6%] vs 376/508 [74.0%]) had a lower RR (.68; .63-.75). There was no significant difference in clinical outcomes.
CONCLUSIONS
This study found that a diagnostic intervention for management of febrile outpatients did not achieve the desired impact on antibiotic prescribing at 3 diverse and representative health facility sites in Uganda.
Identifiants
pubmed: 37490746
pii: 7231003
doi: 10.1093/cid/ciad341
pmc: PMC10368415
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Randomized Controlled Trial
Multicenter Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
S156-S170Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Déclaration de conflit d'intérêts
Potential conflicts of interest. S. D., O. S., P. O., and J. N. were employees of FIND. P. H. reports research funding from FIND and an honoraria payment from Oxford International Biomedical Centre (OIBC). H. H. is a salaried employee of the London School of Hygiene and Tropical Medicine and received separate financial support from the study sponsors for some work on the project reported in this supplement. They receive salary support from the UK Foreign Commonwealth and Development Office. They receive royalties from UpToDate, a clinical decision support tool from Wolters Kluwer for authoring and maintaining the chapter on “Laboratory tools for diagnosis of malaria.” During the study period, they received honoraria for lecturing for the University of Virginia and for a doctoral thesis review for the University of Otago in New Zealand. They also hold index-linked mutual fund and retirement account investments. S. W. reports grant funding from FIND for statistical analysis and services from Agentur für Computeranwendungen in der Medizin (ACOMED). T. K. reports statistical design and analysis grant funding and consultation fees from FIND. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Références
Clin Microbiol Infect. 2018 Aug;24(8):808-814
pubmed: 29454844
Pediatr Infect Dis J. 2022 Mar 1;41(3S):S18-S25
pubmed: 35134036
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
J Glob Antimicrob Resist. 2022 Jun;29:513-519
pubmed: 34890831
J Pediatric Infect Dis Soc. 2016 Jun;5(2):190-205
pubmed: 27059657
Acta Trop. 2012 Mar;121(3):184-95
pubmed: 21420377
Malar J. 2020 Dec 2;19(1):445
pubmed: 33267886
BMJ Open. 2020 Jul 21;10(7):e035632
pubmed: 32699131
Malar J. 2016 Aug 04;15(1):396
pubmed: 27488343
PLoS One. 2020 Dec 28;15(12):e0243868
pubmed: 33370280
Bull World Health Organ. 2015 Dec 1;93(12):862-6
pubmed: 26668438
Clin Infect Dis. 2017 Aug 01;65(3):453-460
pubmed: 28369387
Trop Med Infect Dis. 2021 Sep 29;6(4):
pubmed: 34698282
BMJ. 2017 Mar 29;356:j1054
pubmed: 28356302
ACS Pharmacol Transl Sci. 2020 May 12;3(3):401-417
pubmed: 32551433
Am J Trop Med Hyg. 2017 Oct;97(4):1170-1179
pubmed: 28820705
PLoS One. 2011 Jan 19;6(1):e16316
pubmed: 21283815
Malar J. 2013 Aug 26;12:293
pubmed: 23977904
Trials. 2020 Nov 25;21(1):974
pubmed: 33239106
JAC Antimicrob Resist. 2022 Sep 05;4(5):dlac091
pubmed: 36072304
Lancet Glob Health. 2020 Jun;8(6):e799-e807
pubmed: 32446345
BMC Med. 2020 Jan 30;18(1):17
pubmed: 31996199
Trop Med Int Health. 2015 Dec;20(12):1696-706
pubmed: 26311240
Trop Med Int Health. 2021 Dec;26(12):1668-1676
pubmed: 34598312
Clin Microbiol Infect. 2017 Nov;23(11):812-818
pubmed: 28712667
BMJ Open. 2017 Mar 8;7(3):e012973
pubmed: 28274962